Evolent Health, Inc. (EVH)
After hours:
Chart Events
Performance Outlook
| Previous Close | 34.47 |
| Open | 34.32 |
| Bid | 34.96 x 1000 |
| Ask | 34.97 x 1000 |
| Day's Range | 33.92 - 35.07 |
| 52 Week Range | 21.36 - 39.00 |
| Volume | |
| Avg. Volume | 997,701 |
| Market Cap | 3.208B |
| Beta (5Y Monthly) | 1.86 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.38 |
| Earnings Date | Nov 01, 2022 - Nov 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.14 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for EVH
Related Research
- Evolent Health, IncTechnical Assessment: Neutral in the Intermediate-TermThere's been a lot of talk, mostly among technicians, about the belief that when the S&P 500 retraces 50% of its correction/bear market, the closing lows are in and investors can respond accordingly. Well, even if it was that simple, it doesn't always work. During major meltdowns, you might miss a massive rally if you waited for the "500" to see that kind or retracement. We also question any focus on a single percentage rather than a range. What if the "500" retraces 49%? Is that no good?RatingFair ValueEconomic Moat8 days agoArgus Research
- Zacks
What Makes Evolent Health (EVH) a Strong Momentum Stock: Buy Now?
Does Evolent Health (EVH) have what it takes to be a top stock pick for momentum investors? Let's find out.
- PR Newswire
Evolent Health to Participate in the CG Growth Conference
Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley and Vice President, Investor Relations Seth Frank will conduct investor meetings and host a presentation at the Canaccord Genuity 42nd Annual Growth Conference at The Intercontinental Boston Hotel, Boston, Mass., on Wednesday, August 10, 2022 at 4:30 p.m. ET.
- Zacks
Wall Street Analysts Predict a 28% Upside in Evolent Health (EVH): Here's What You Should Know
The consensus price target hints at a 28.3% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
